Table 4 Mapping analysis provided by Reactome for the bi53 bicluster obtained with the (212)-simGIC fitness function
From: Pairwise gene GO-based measures for biclustering of high-dimensional expression data
Pathway identifier | Pathway name | FDR | Entities | Entities |
|---|---|---|---|---|
found | total | |||
R-HSA-3304347 | Loss of Function of SMAD4 in Cancer | 5.27E-11 | 2 | 3 |
R-HSA-3311021 | SMAD4 MH2 Domain Mutants in Cancer | 5.27E-11 | 2 | 3 |
R-HSA-3304356 | SMAD2/3 Phosphorylation Motif Mutants in Cancer | 0.002 | 2 | 7 |
R-HSA-3304349 | Loss of Function of SMAD2/3 in Cancer | 0.002 | 2 | 9 |
R-HSA-3315487 | SMAD2/3 MH2 Domain Mutants in Cancer | 0.002 | 2 | 9 |
R-HSA-3656532 | TGFBR1 KD Mutants in Cancer | 0.002 | 2 | 9 |
R-HSA-3656534 | Loss of Function of TGFBR1 in Cancer | 0.002 | 2 | 9 |
R-HSA-3304351 | Signaling by TGF-beta Receptor Complex in Cancer | 0.002 | 2 | 10 |
R-HSA-2894858 | Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 0.017 | 2 | 68 |
R-HSA-2644602 | Signaling by NOTCH1 PEST Domain Mutants in Cancer | 0.017 | 2 | 68 |
R-HSA-2644603 | Signaling by NOTCH1 in Cancer | 0.017 | 2 | 68 |